BACKGROUND: Organisms expressing Klebsiella pneumoniae carbapenemase (KPC) are found in several regions worldwide but are rarely detected in Canada. The first outbreak of KPC-expressing strains of Enterobacteriaceae clinical isolates in a university-affiliated hospital intensive care unit (ICU) in Canada is described. METHODS: Enterobacteriaceae isolates that were flagged by the Vitek 2 (bioMérieux, France) system as possible carbapenemase producers were subjected to the modified Hodge test. Modified Hodge test-positive organisms were analyzed by pulsed-field gel electrophoresis, tested for KPC and other beta-lactamase genes by polymerase chain reaction analysis and underwent subsequent nucleic acid sequencing. Antimicrobial susceptibility profiles were determined by Vitek 2 and Etest (bioMérieux, France). A chart review was conducted to establish epidemiological links. RESULTS: During the study period, 10 unique Enterobacteriaceae isolates expressing KPC were detected from nine ICU patients. Five patients had infections (three pneumonias, one surgical site infection, one urinary tract infection). Isolates included Escherichia coli (5), Klebsiella oxytoca (2), Serratia marcescens (2) and Citrobacter freundii (1). Polymerase chain reaction analysis and sequencing confirmed the presence of KPC-3 in all isolates; four also carried TEM, two CTX-M and one CMY-2. The imipenem minimum inhibitory concentrations as determined by Etest ranged from 0.75 μg/mL to ≥32 μg/mL. Pulsed field gel electrophoresis clonal patterns and patient location in the ICU revealed presumptive horizontal transmission events. CONCLUSIONS: In the present study, Enterobacteriaceae isolates with KPC are emerging and can result in serious infections. The KPC gene can spread via plasmids to different genera of the Enterobacteriaceae family. The dissemination of KPC in Enterobacteriaceae and the consequences for treatment and infection control measures warrant a high degree of vigilance among clinicians and microbiologists.
BACKGROUND: Organisms expressing Klebsiella pneumoniae carbapenemase (KPC) are found in several regions worldwide but are rarely detected in Canada. The first outbreak of KPC-expressing strains of Enterobacteriaceae clinical isolates in a university-affiliated hospital intensive care unit (ICU) in Canada is described. METHODS: Enterobacteriaceae isolates that were flagged by the Vitek 2 (bioMérieux, France) system as possible carbapenemase producers were subjected to the modified Hodge test. Modified Hodge test-positive organisms were analyzed by pulsed-field gel electrophoresis, tested for KPC and other beta-lactamase genes by polymerase chain reaction analysis and underwent subsequent nucleic acid sequencing. Antimicrobial susceptibility profiles were determined by Vitek 2 and Etest (bioMérieux, France). A chart review was conducted to establish epidemiological links. RESULTS: During the study period, 10 unique Enterobacteriaceae isolates expressing KPC were detected from nine ICU patients. Five patients had infections (three pneumonias, one surgical site infection, one urinary tract infection). Isolates included Escherichia coli (5), Klebsiella oxytoca (2), Serratia marcescens (2) and Citrobacter freundii (1). Polymerase chain reaction analysis and sequencing confirmed the presence of KPC-3 in all isolates; four also carried TEM, two CTX-M and one CMY-2. The imipenem minimum inhibitory concentrations as determined by Etest ranged from 0.75 μg/mL to ≥32 μg/mL. Pulsed field gel electrophoresis clonal patterns and patient location in the ICU revealed presumptive horizontal transmission events. CONCLUSIONS: In the present study, Enterobacteriaceae isolates with KPC are emerging and can result in serious infections. The KPC gene can spread via plasmids to different genera of the Enterobacteriaceae family. The dissemination of KPC in Enterobacteriaceae and the consequences for treatment and infection control measures warrant a high degree of vigilance among clinicians and microbiologists.
Authors: Gordon Guyatt; David Gutterman; Michael H Baumann; Doreen Addrizzo-Harris; Elaine M Hylek; Barbara Phillips; Gary Raskob; Sandra Zelman Lewis; Holger Schünemann Journal: Chest Date: 2006-01 Impact factor: 9.410
Authors: F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan Journal: J Clin Microbiol Date: 1995-09 Impact factor: 5.948
Authors: J Kamile Rasheed; James W Biddle; Karen F Anderson; Laraine Washer; Carol Chenoweth; John Perrin; Duane W Newton; Jean B Patel Journal: J Clin Microbiol Date: 2008-04-02 Impact factor: 5.948
Authors: K F Anderson; D R Lonsway; J K Rasheed; J Biddle; B Jensen; L K McDougal; R B Carey; A Thompson; S Stocker; B Limbago; J B Patel Journal: J Clin Microbiol Date: 2007-06-20 Impact factor: 5.948
Authors: Fred C Tenover; Rajinder K Kalsi; Portia P Williams; Roberta B Carey; Sheila Stocker; David Lonsway; J Kamile Rasheed; James W Biddle; John E McGowan; Bruce Hanna Journal: Emerg Infect Dis Date: 2006-08 Impact factor: 6.883
Authors: Inna Sekirov; Matthew A Croxen; Corrinne Ng; Robert Azana; Yin Chang; Laura Mataseje; David Boyd; Chand Mangat; Benjamin Mack; Manal Tadros; Elizabeth Brodkin; Pamela Kibsey; Aleksandra Stefanovic; Sylvie Champagne; Michael R Mulvey; Linda M N Hoang Journal: J Clin Microbiol Date: 2015-11-25 Impact factor: 5.948
Authors: Louis-Patrick Haraoui; Simon Lévesque; Brigitte Lefebvre; Ruth Blanchette; Melissa Tomkinson; Laura Mataseje; Michael R Mulvey; Mark A Miller Journal: J Clin Microbiol Date: 2013-05-01 Impact factor: 5.948
Authors: Nathalie Tijet; Prameet M Sheth; Olga Lastovetska; Catherine Chung; Samir N Patel; Roberto G Melano Journal: PLoS One Date: 2014-12-30 Impact factor: 3.240
Authors: Laura F Mataseje; Kahina Abdesselam; Julie Vachon; Robyn Mitchel; Elizabeth Bryce; Diane Roscoe; David A Boyd; Joanne Embree; Kevin Katz; Pamela Kibsey; Andrew E Simor; Geoffrey Taylor; Nathalie Turgeon; Joanne Langley; Denise Gravel; Kanchana Amaratunga; Michael R Mulvey Journal: Antimicrob Agents Chemother Date: 2016-10-21 Impact factor: 5.191
Authors: Daleen Loest; F Carl Uhland; Kaitlin M Young; Xian-Zhi Li; Michael R Mulvey; Richard Reid-Smith; Lauren M Sherk; Carolee A Carson Journal: Epidemiol Infect Date: 2022-06-29 Impact factor: 4.434
Authors: Brigitte Lefebvre; Simon Lévesque; Anne-Marie Bourgault; Michael R Mulvey; Laura Mataseje; David Boyd; Florence Doualla-Bell; Cécile Tremblay Journal: PLoS One Date: 2015-04-24 Impact factor: 3.240